Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

4.0K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.0K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

4.7K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.7K
Abnormal Proliferation02:23

Abnormal Proliferation

4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

8.6K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retinoic Acid Receptor γ Activity Plays a Critical Role in Regulating Early Mouse Gastruloid Development.

International journal of molecular sciences·2026
Same author

The Influences of RARγ on the Behavior of Normal and Cancer Stem Cells.

International journal of molecular sciences·2026
Same author

Special Issue "Novel Strategies in the Development of New Therapies, Drug Substances and Drug Carriers, 3rd Edition".

International journal of molecular sciences·2025
Same author

Cell Lineage Affiliation During Hematopoiesis.

International journal of molecular sciences·2025
Same author

Targeting Androgen, Thyroid Hormone, and Vitamin A and D Receptors to Treat Prostate Cancer.

International journal of molecular sciences·2024
Same author

Molecular Interactions of Selective Agonists and Antagonists with the Retinoic Acid Receptor γ.

International journal of molecular sciences·2024

Related Experiment Video

Updated: May 17, 2025

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

6.5K

The Emerging Oncogenic Role of RARγ: From Stem Cell Regulation to a Potential Cancer Therapy.

Geoffrey Brown1

  • 1Department of Biomedical Sciences, School of Infection, Inflammation, and Immunology, College of Medicine and Health, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.

International Journal of Molecular Sciences
|May 14, 2025
PubMed
Summary

Retinoic acid receptor gamma (RARγ) is crucial for maintaining healthy stem cells. However, its aberrant expression drives various cancers, making RARγ a potential therapeutic target for cancer treatment.

Keywords:
cancer stem cellscarcinomacell developmentnormal stem cellsretinoic acid receptor γtherapeutics

More Related Videos

Prediction and Validation of Gene Regulatory Elements Activated During Retinoic Acid Induced Embryonic Stem Cell Differentiation
09:07

Prediction and Validation of Gene Regulatory Elements Activated During Retinoic Acid Induced Embryonic Stem Cell Differentiation

Published on: June 21, 2016

8.2K
Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines
00:09

Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines

Published on: August 21, 2019

6.9K

Related Experiment Videos

Last Updated: May 17, 2025

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

6.5K
Prediction and Validation of Gene Regulatory Elements Activated During Retinoic Acid Induced Embryonic Stem Cell Differentiation
09:07

Prediction and Validation of Gene Regulatory Elements Activated During Retinoic Acid Induced Embryonic Stem Cell Differentiation

Published on: June 21, 2016

8.2K
Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines
00:09

Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines

Published on: August 21, 2019

6.9K

Area of Science:

  • Hematology
  • Oncology
  • Molecular Biology

Background:

  • Retinoic acid receptor gamma (RARγ) expression is specifically observed in adult hematopoietic stem cells, playing a vital role in their maintenance.
  • RARγ is selectively expressed in stem cells, and its activation can impede stem cell development.

Purpose of the Study:

  • To investigate the dual role of RARγ in both normal stem cell function and oncogenesis.
  • To explore the potential of targeting RARγ for cancer therapy.

Main Methods:

  • Analysis of RARγ expression patterns in various cancer types and normal tissues.
  • Evaluation of the effects of RARγ agonism and antagonism on cancer cell proliferation and survival.
  • Correlation of RARγ expression levels with clinical parameters such as disease grade and patient prognosis.

Main Results:

  • RARγ exhibits an oncogenic role in multiple cancers, including acute myeloid leukemia, cholangiocarcinoma, and various solid tumors.
  • Overexpression or agonism of RARγ promotes proliferation in certain cancers (e.g., head and neck, hepatocellular, prostate).
  • RARγ antagonism or downregulation inhibits cancer cell growth and survival, often leading to cell death in hematological and solid malignancies.
  • High RARγ expression is linked to advanced disease, metastasis, and poor prognosis in several cancer types.

Conclusions:

  • RARγ is a critical regulator of stem cell homeostasis and a significant driver of cancer cell growth and survival.
  • Targeting RARγ presents a promising therapeutic strategy for a range of malignancies, particularly those expressing it in cancer stem cells.